OrbiMed’s Bristol-Myers Squibb BMY Stock Holding History

OrbiMed’s Portfolio BMY Stock Details BMY Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,488,000	Closed	-$95.2M	–	123
2023 Q2	$95.2M	Sell	1,488,000 -852,000	-36%	-$54.5M	1.72%	15
2023 Q1	$162M	Sell	2,340,000 -244,900	-9%	-$17M	3.18%	5
2022 Q4	$186M	Hold	2,584,900	–	–	3.56%	3
2022 Q3	$184K	Buy	2,584,900 +66,200	+3%	+$4.71K	3.41%	2
2022 Q2	$194K	Sell	2,518,700 -89,000	-3%	-$6.85K	3.51%	2
2022 Q1	$190M	Sell	2,607,700 -1,732,100	-40%	-$126M	3.09%	6
2021 Q4	$271M	Sell	4,339,800 -175,600	-4%	-$10.9M	3.48%	2
2021 Q3	$267M	Hold	4,515,400	–	–	2.94%	5
2021 Q2	$302M	Hold	4,515,400	–	–	3.05%	2
2021 Q1	$285M	Buy	4,515,400 +966,300	+27%	+$61M	2.67%	8
2020 Q4	$220M	Hold	3,549,100	–	–	1.93%	11
2020 Q3	$214M	Buy	3,549,100 +666,900	+23%	+$40.2M	2.69%	10
2020 Q2	$169M	Buy	2,882,200 +407,400	+16%	+$24M	2.39%	13
2020 Q1	$138M	Buy	2,474,800 +774,800	+46%	+$43.2M	2.32%	13
2019 Q4	$109M	Buy	+1,700,000	New	+$109M	1.56%	16
2019 Q3	–	Sell	-1,345,200	Closed	-$61M	–	114
2019 Q2	$61M	Buy	1,345,200 +150,200	+13%	+$6.81M	0.94%	35
2019 Q1	$57M	Buy	1,195,000 +689,100	+136%	+$32.9M	0.88%	35
2018 Q4	$26.3M	Sell	505,900 -1,519,900	-75%	-$79M	0.49%	59
2018 Q3	$126M	Sell	2,025,800 -354,500	-15%	-$22M	1.51%	20
2018 Q2	$132M	Sell	2,380,300 -1,295,000	-35%	-$71.7M	1.57%	15
2018 Q1	$232M	Buy	3,675,300 +2,987,300	+434%	+$189M	2.88%	8
2017 Q4	$42.2M	Sell	688,000 -186,700	-21%	-$11.4M	0.53%	58
2017 Q3	$55.8M	Hold	874,700	–	–	0.53%	56
2017 Q2	$48.7M	Sell	874,700 -1,036,300	-54%	-$57.7M	0.51%	57
2017 Q1	$104M	Buy	1,911,000 +417,500	+28%	+$22.7M	1.18%	29
2016 Q4	$87.3M	Sell	1,493,500 -693,900	-32%	-$40.6M	1.11%	31
2016 Q3	$118M	Sell	2,187,400 -2,868,200	-57%	-$155M	1.34%	26
2016 Q2	$372M	Sell	5,055,600 -2,569,300	-34%	-$189M	3.88%	4
2016 Q1	$487M	Sell	7,624,900 -770,100	-9%	-$49.2M	5.13%	1
2015 Q4	$577M	Sell	8,395,000 -273,100	-3%	-$18.8M	5.23%	1
2015 Q3	$513M	Buy	8,668,100 +917,000	+12%	+$54.3M	5.18%	1
2015 Q2	$516M	Sell	7,751,100 -1,131,700	-13%	-$75.3M	4.31%	2
2015 Q1	$573M	Buy	8,882,800 +1,194,100	+16%	+$77M	4.89%	1
2014 Q4	$454M	Buy	7,688,700 +396,700	+5%	+$23.4M	4.34%	2
2014 Q3	$373M	Buy	7,292,000 +103,000	+1%	+$5.27M	3.9%	3
2014 Q2	$349M	Buy	7,189,000 +1,222,600	+20%	+$59.3M	4.09%	2
2014 Q1	$310M	Buy	5,966,400 +501,400	+9%	+$26M	3.81%	4
2013 Q4	$290M	Buy	5,465,000 +261,000	+5%	+$13.9M	4.27%	4
2013 Q3	$241M	Buy	5,204,000 +1,882,000	+57%	+$87.1M	4.3%	5
2013 Q2	$148M	Buy	+3,322,000	New	+$148M	3.15%	7